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Allopregnanolone and Pentobarbital Infused Into the
Nucleus Accumbens Substitute for the Discriminative
Stimulus Effects of Ethanol
Clyde W. Hodge, Michelle A. Nannini, M. Foster Olive, Stephen P. Kelley, and Kristin K. Mehmert
Background: The discriminative stimulus effects of ethanol are mediated in part by the -aminobutyric
acid type A (GABAA) receptor system. We have previously shown that microinjections of the competitive
GABAA agonist muscimol in the nucleus accumbens and amygdala fully substitute for the discriminative
stimulus effects of systemic ethanol. However, it is not known whether allosteric binding sites on GABAA
receptors located within specific limbic brain regions contribute to the discriminative stimulus effects of
ethanol.
Methods: Male Long-Evans rats were trained to discriminate between intraperitoneal injections of
ethanol (1 g/kg) and saline under a fixed-ratio 10 schedule of sucrose (10% w/v) reinforcement. Injector
guide cannulae, aimed at both the nucleus accumbens core and the hippocampus area CA1, were then
implanted to allow site-specific infusion of GABAA-positive modulators.
Results: Infusion of the neurosteroid 3-hydroxy-5-pregnan-20-one (allopregnanolone, or 3-5-P) in
the nucleus accumbens resulted in dose-dependent full substitution for intraperitoneal ethanol (50%
effective dose  0.38 ng/l per side). Likewise, injection of the barbiturate pentobarbital into the nucleus
accumbens also substituted dose-dependently for ethanol (50% effective dose  1.55 g/l per side).
However, infusions of either 3-5-P or pentobarbital in the hippocampus failed to substitute for ethanol
and produced inverted U-shaped dose-response curves.
Conclusions: These results demonstrate that allosteric positive modulation of GABAA receptors in the
nucleus accumbens produces full substitution for the stimulus effects of ethanol. This suggests that GABAA
receptors in the nucleus accumbens may play a more influential role in the discriminative stimulus effects
of ethanol than those in the hippocampus.
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ETHANOL’S EFFECTS ON brain and behavioral pro-cesses are mediated, in part, by changes in ionotropic
-aminobutyric acid type A (GABAA) receptor function
(see Grobin et al., 1998). Acute ethanol enhances neuronal
Cl influx (Mehta and Ticku, 1988; Suzdak et al., 1986) and
potentiates GABA-induced (Ticku, 1990) and muscimol-
induced (Suzdak et al., 1986) Cl influx in various brain
regions. These positive actions on GABAA receptors also
seem to influence ethanol’s anxiolytic (Liljequist and Engel,
1984), motor (Frye and Breese, 1982), and reinforcing
(Hodge et al., 1995) effects.
GABAA receptor–mediated Cl
 conductance is posi-
tively modulated at a GABA recognition site, but also at
allosteric sites that bind benzodiazepines, barbiturates, and
neuroactive steroids (Peters et al., 1988; Study and Barker,
1981). Accordingly, positive modulators of GABAA recep-
tors substitute for ethanol in drug discrimination studies.
Systemically administered barbiturates substitute for etha-
nol (Barry, 1991; Barry and Krimmer, 1978; Kline and
Young, 1986; Overton, 1977; York and Bush, 1982), and
ethanol potentiates stimulus control by pentobarbital
(Kline and Young, 1986). Benzodiazepines also substitute
for ethanol (Hiltunen and Jarbe, 1986; Kubena and Barry,
1969) and potentiate ethanol discrimination (Jarbe and
McMillan, 1983). More recent evidence indicates that var-
ious endogenous neuroactive steroids with positive
GABAA receptor–modulating properties, including 3-
hydroxy-5-pregnan-20-one (allopregnanolone, or 3-5-
P), also substitute for ethanol (Bienkowski and Kostowski,
1997; Bowen et al., 1999a; Grant et al., 1996, 1997) and
potentiate ethanol discrimination (Bowen et al., 1999b).
However, because GABAA receptor systems are distrib-
uted throughout the mammalian brain (Pirker et al., 2000;
Rabow et al., 1995; Sperk et al., 1997; Wisden et al., 1992),
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systemic administration studies cannot determine the ex-
tent to which ethanol’s discriminative stimulus effects are
mediated by receptor activity in specific brain regions.
We recently demonstrated that microinfusions of the
direct GABAA receptor agonist muscimol into the core
region of the nucleus accumbens substitute for and poten-
tiate the discriminative stimulus effects of systemically ad-
ministered ethanol (Hodge and Aiken, 1996; Hodge and
Cox, 1998). It is not known, however, whether positive
allosteric modulation of GABAA receptors in the nucleus
accumbens contributes to the discriminative stimulus ef-
fects of ethanol. Therefore, the purpose of this study was to
investigate whether microinjections of positive allosteric
GABAA receptor modulators into the nucleus accumbens
or other brain regions would substitute for the stimulus
effects of ethanol in drug discrimination procedures.
MATERIALS AND METHODS
Animals
Male Long-Evans rats (n  12; Charles River Laboratories, Wilming-
ton, MA) were individually housed in Plexiglas (Rohm and Haas Co.,
Philadelphia, PA) cages with water available ad libitum. Body weights
were maintained at approximately 310  15 g via food restriction. The
colony room was regulated on a 12-hr light/dark cycle with lights on at 6:00
AM. Experiments were conducted during the light portion of the cycle. All
rats were weighed and inspected each day for general health. Rats were
experimentally and drug naïve at beginning of the study. All animal
procedures were conducted according to the Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory Animals Resources, 1996).
Apparatus
Discrimination sessions were conducted in 31  32  24 cm operant
chambers located within sound-attenuating cubicles with exhaust fans that
helped to mask external noise (Med Associates, Georgia, VT). Responses
on one of two levers located on the right wall activated a liquid dispenser
centered between the two levers that presented fluid in a 0.1-ml dipper for
4 sec during each operation. The operant chambers were interfaced (Med
Associates) with a computer (Gateway, San Diego, CA) that was pro-
grammed to control sessions and record data. Chambers were illuminated
with an 8-W light located on the left wall 28 cm above the dipper.
Drug Discrimination Procedures: Training
Rats were allowed 1 week to adapt to individual housing conditions and
daily handling. During this time, food and water were always available.
Once target body weights were reached, food was restricted to approxi-
mately 16 g/day. Rats were trained to press a single lever on a fixed-ratio
1 (FR 1) schedule of reinforcement that resulted in presentation of 0.1 ml
of a liquid sucrose solution (10% w/v). After 3 days, they were then trained
to press either the left or the right lever during daily 30-min sessions. The
active lever was alternated on a daily basis. Responses on the inactive lever
were recorded but produced no programmed consequences. The schedule
of reinforcement was gradually increased to FR 10, with only one lever
active on any particular session. All animals received an equal history with
each lever at each FR value. Once responding was stable (10% daily
variation in the total number of responses), discrimination training was
initiated.
Training sessions were conducted 5 days per week (Monday through
Friday), during which ethanol 1.0 g/kg or saline was administered intra-
peritoneally (ip) 10 min before the start of 15-min sessions. The animals
were placed in the operant chambers, and illumination of the house light
signaled the beginning of the session. The lever associated with ethanol or
saline administration was assigned randomly and counterbalanced be-
tween animals. After ethanol or saline injections, completion of 10 re-
sponses on the appropriate lever produced the sucrose solution. Re-
sponses on the inappropriate lever were recorded but produced no
programmed consequences. There were an equal number of ethanol and
saline training days that varied on a double-alternation schedule (ethanol,
ethanol, saline, saline, and so on). Training sessions were conducted until
the percentage of ethanol- and saline-appropriate lever press responses
emitted before the first reinforcer, and during the entire session, exceeded
80% for 10 consecutive days. These criteria allowed no more than two
errors before completion of the first FR 10. Once the accuracy criteria
were met, injector guide cannulae were surgically implanted to terminate
1 mm dorsal to the nucleus accumbens core and hippocampal area CA1.
Surgery
Rats were anesthetized with pentobarbital (60 mg/kg ip) and placed in
a stereotaxic device (David Kopf Instruments, Tujunga, CA) with the
incisor bar 3.3 mm below the horizontal plane. Bilateral guide cannulae
(26-guage stainless-steel tubing) were implanted to terminate 1 mm dorsal
to the nucleus accumbens core and hippocampal area CA1. Cannulae
were secured with stainless-steel screws and dental cement. Stylets were
placed in the cannulae to prevent obstructions and infections. Stereotaxic
coordinates according to the atlas of Paxinos and Watson (1997) for brain
sites were nucleus accumbens, 1.5 mm Anterior/Posterior, 3.0 mm
Medial/Lateral, and 6.1 mm Dorsal/Ventral at 10° deviations from ver-
tical; and CA1, 4.4 mm Anterior/Posterior, 3.3 mm Medial/Lateral,
and 2.2 mm Dorsal/Ventral at 20° deviations from vertical. Behavioral
sessions resumed 1 week after surgery to allow for recovery.
Intraperitoneal Ethanol Substitution Testing
Training sessions were resumed after recovery from surgery and con-
tinued until performance after ip injections of ethanol and saline again
met the accuracy criteria. Once this was accomplished, test sessions were
conducted during which an ethanol (0.1–1.5 g/kg ip) substitution curve was
determined. Test sessions were identical to training sessions except for the
following: they were 2 min in duration, completion of an FR 10 on either
lever produced the sucrose solution, and novel doses of ethanol were
administered. Test sessions were interspersed randomly with training
sessions only if performance during the previous 10 training sessions met
the accuracy criteria. If performance during continued training sessions
failed to meet the accuracy criteria, testing was delayed until response
accuracy was greater than 80% for 10 consecutive days. A minimum of two
training sessions were conducted between test sessions. After determina-
tion of the ip ethanol substitution curve, microinjection test sessions
began.
Site-Specific Microinjection Procedure
Drugs were administered through stainless-steel injectors (33-gauge
tubing linked to 26-gauge tubing, Plastics One, Roanoke, VA) that were
coupled via PE-20 plastic tubing to two 1.0-l Hamilton syringes. Syringes
were mounted on a Harvard Apparatus (Holliston, MA) microinfusion
pump that delivered 0.5 l per side per minute. Microinjection test
sessions were interspersed randomly with training sessions if performance
during the previous 10 training sessions met the accuracy criteria. Unanes-
thetized rats were placed in a plastic tub (27  17  12 cm) to minimize
movement. Stylets were removed, and the cannulae were swabbed with
sterile physiologic saline. Bilateral drug injections were performed
through 33-gauge stainless-steel hypodermic tubing lowered to 1 mm
below the end of the guide cannulae. The pump was operated for 1 min at
a flow rate of 0.5 l per side per minute for a total volume of 0.5 l per
side. Injectors remained in place for 30 additional seconds to allow drug
diffusion; ip saline or ethanol was administered immediately, and the rats
were placed in the operant chambers. The beginning of test sessions was
signaled by illumination of the house light at 10 min after microinjections.
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Sham injections were performed in combination with the training dose
of ethanol (1.0 g/kg) and saline as a procedural control for possible
handling effects. Sham control injections were identical to actual micro-
injections except that injectors were the same lengths as the guide cannu-
lae to prevent brain penetration and, although the pumps were operated,
the syringes were not activated.
Drugs and Dosing
Drug solutions were prepared immediately before injection. For sys-
temic administration, ethanol (95% w/v) was diluted in saline (0.9%) to a
concentration of 20% v/v and was administered ip in varied volumes to
obtain doses of 0.1, 0.5, 1.0, and 1.5 g/kg. Corresponding volumes of saline
(0.9%) were also administered. For central administration, 3-5-P was
dissolved in (2-hydroxypropyl)--cyclodextrin (45% w/v) in sterile deion-
ized water. Pentobarbital was dissolved in sterile deionized water. All
drugs and reagents were purchased from Sigma-Aldrich (St. Louis, MO).
3-5-P and pentobarbital were tested for ethanol substitution after
administration in the hippocampus (CA1) or nucleus accumbens core.
Both drugs were tested first in the hippocampus and then in the nucleus
accumbens. Drug (dose) order was as follows: hippocampus [3-5-P (1.0,
0.33, 2.0, and 0.55 ng/l) and pentobarbital (0.5, 5.0, and 20.0 g/l)] and
nucleus accumbens [3-5-P (0.33, 0.1, and 0.55 ng/l) and pentobarbital
(0.5 and 5.0 g/l)]. The effects of each dose were determined once in
each animal.
Histology
Once the experiment was completed, the rats were deeply anesthetized
with pentobarbital and then perfused transcardially with sodium phos-
phate buffer solution (pH 7.5) followed by 10% formalin. Brains were
removed and stored in a solution of 10% formalin/30% sucrose for at least
7 days. The brains were then sliced into 30-m sections and stained with
cresyl violet. Cannulae placement was verified with a standard light mi-
croscope (Bausch and Lomb, Rochester, NY). The data were compiled
from only the bilateral injections determined to be within the target brain
regions.
Data Analysis
Accuracy of responses was expressed as a percentage of total ethanol-
appropriate lever presses during the entire session. Response rate (re-
sponses per minute) was analyzed for the entire session as a measure of
possible nonspecific effects on behavior. Group averages of ethanol and
saline training 5 days immediately before the onset of testing represented
control performance for effects of ip ethanol. Sham injection performance
was used as the control for microinjection data. Complete substitution for
the ethanol stimulus was defined as 80% choice of the ethanol lever
during the entire session, whereas partial substitution was defined as
between 40% and 80% ethanol-lever responding. Response rates were
analyzed for statistical differences with repeated-measures ANOVA with
Tukey’s post hoc comparison. The 50% effective dose (ED50) values were
determined by log-dose probit analysis. Data were used only from animals
determined histologically to have bilateral injectors in target brain regions




Histological examination of coronal brain sections
showed that the injectors were bilaterally located in the
targeted brain areas of nine rats. The range of injector
locations in each brain region studied is shown in Fig. 1.
Injectors in the nucleus accumbens were located in the
nucleus accumbens core or at the core/shell border. Hip-
pocampus injections were in the medial dorsal region near
CA1. Data are presented only from animals that received
bilateral microinjections in the specified brain areas.
Acquisition and ip Ethanol Substitution
During the initial training days, the percentage of re-
sponses on the ethanol lever occurred at approximately
chance levels on the two-lever task (i.e., 40–50%). After 52
training days, the behavior of all rats reached the accuracy
criteria of greater than 80% responding on the ethanol
lever after ethanol injection and less than 20% responding
on the ethanol lever after saline injection for 10 consecutive
days.
Performance of all rats during control conditions and
postsurgery ethanol substitution test sessions is shown in
Fig. 2. The percentage of ethanol-lever responding (Fig.
2A) was approximately 95% during ethanol control ses-
sions and5% during saline control sessions; this indicates
that the procedures established reliable stimulus control.
The behavior of all individual animals demonstrated dose-
dependent substitution of ethanol. Whereas the 0.1 g/kg
dose of ethanol had no effect and the 0.5 g/kg dose pro-
duced partial substitution, both the 1.0 and 1.5 g/kg doses
of ethanol substituted fully for the training dose and were
significantly greater than saline [1.0 g/kg, F(1,17)  349.68,
p  0.001; 1.5 g/kg, F(1,17)  4032.80, p  0.001]. The
ED50 for ethanol substitution was 0.69 g/kg (0.07 g/kg).
Responses rates during substitution test sessions at 0.1 (q
4.24, p  0.05), 0.5 [F(1,17)  7.31, p  0.05], and 1.0 (q 
3.30, p  0.05) g/kg doses of ethanol were significantly
higher than during training sessions (Fig. 2B). Response
rates at 1.5 g/kg ethanol during substitution tests were not
different from saline (Fig. 2B).
Fig. 1. Representation of rat coronal brain sections showing histological
localization of injectors. The black dots in each section indicate each individual
injector placement. Data were used only from animals that received bilateral
injections in the target brain regions. Figures are adapted from the atlas of
Paxinos and Watson (1997). Numbers beside each section represent the plane of
the section in millimeters from the bregma. Reprinted with permission.
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3-5-P Infusion Into the Hippocampus or
Nucleus Accumbens
As seen in Fig. 3A, the neurosteroid 3-5-P dose-
dependently substituted for 1.0 g/kg ip ethanol when in-
fused into the nucleus accumbens. Doses of 0.1 and 0.33
ng/l had no effect, whereas a 0.55 ng/l dose fully substi-
tuted for ethanol [F(1,15) 42.84, p 0.001 versus saline].
The ED50 value for ethanol substitution when 3-5-P was
infused into the nucleus accumbens was 0.38  0.11 ng/l.
The response rate was not significantly altered by 3-5-P
infusion into the nucleus accumbens.
Full substitution for ethanol was not observed when
3-5-P was infused into the CA1 region of the hip-
pocampus. Instead, an inverted U-shaped curve resulted,
with the low (0.33 ng/l) and high (2.0 ng/l) doses being
without effect and midrange doses of 0.55 and 1.0 ng/l
partially substituting for ethanol [F(1,17)  14.94, p 
0.05 and F(1,17)  9.35, p  0.05 versus saline, respec-
tively]. Response rates during 3-5-P infusion into the
CA1 at all doses were not significantly different from
saline controls.
Pentobarbital Infusion Into the Hippocampus or
Nucleus Accumbens
As seen in Fig. 4A, pentobarbital dose-dependently sub-
stituted for 1.0 g/kg ip ethanol when infused into the nu-
cleus accumbens. The 0.5 g/l dose had no effect, whereas
a 5 g/l dose fully substituted for ethanol [F(1,15) 
13.38, p  0.05 versus saline]. The ED50 for ethanol sub-
stitution when pentobarbital was infused into the nucleus
accumbens was 1.55  0.10 g/l. Response rates during
pentobarbital infusion into the nucleus accumbens at both
doses tested were not significantly different from saline
controls.
Full substitution for ethanol was not observed when
pentobarbital was infused into the CA1 region of the hip-
Fig. 2. Mean  SEM percentage of ethanol-appropriate responses (A) and
mean  SEM total session response rate (B) plotted as a function of ethanol
dosage. Data points to the left of the x axis break represent performance during
the last saline (S) or ethanol (E; EtOH) training session before the start of the test
sessions. Data points to the right of the x axis break represent test session
performance after ip ethanol administration. Training and test sessions began 10
min after ip ethanol administration. The horizontal dashed line (80%) represents
full substitution for the discriminative stimulus effects of ethanol (1.0 g/kg ip). All
points represent the mean performance of nine animals. *p 0.001 versus saline.
Fig. 3. Mean  SEM percentage of ethanol-appropriate responses (A) and
mean  SEM total session response rate (B) plotted as a function of 3-5-P
dosage. Rats received 3-5-P injections in the nucleus accumbens (F, n  9) or
dorsal CA1 region of the hippocampus (, n  9). Data points to the left of the x
axis break represent control saline (S) or ethanol (E) ip performance combined
with sham microinjections. The horizontal dashed line (80%) represents full
substitution for the discriminative stimulus effects of ethanol (1.0 g/kg ip). Drugs
and doses were administered in a randomized order. *p  0.05 versus saline. **p
 0.001 versus saline.
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pocampus. The low (0.5 g/l) dose was without effect,
whereas higher doses of 5 and 20 g/l partially substituted
for ethanol [F(1,15)  5.70, p  0.05 and F(1,15)  10.03,
p  0.05 versus saline, respectively]. Response rates after
pentobarbital infusion into the CA1 at all three doses were
not significantly different from saline controls.
DISCUSSION
The main finding of this study is that infusion of positive
allosteric GABAA receptor modulators into the nucleus
accumbens produces full substitution for the discriminative
stimulus effects of systemically administered ethanol.
These data extend other findings that showed that systemic
administration of positive modulators of GABAA recep-
tors, such as barbiturates (Barry and Krimmer, 1978; Kline
and Young, 1986; Overton, 1977; York and Bush, 1982)
and endogenous neuroactive steroids (Bienkowski and Ko-
stowski, 1997; Bowen et al., 1999a; Grant et al., 1996, 1997),
substitutes fully for the discriminative stimulus effects of
systemically administered ethanol. Results from this study
demonstrate that site-specific infusion of pentobarbital or
3-5-P produces discriminative stimulus effects that cor-
respond to those of systemic ethanol. Moreover, the results
of this study agree with previous findings, which demon-
strated that the direct GABAA agonist muscimol substi-
tutes fully for systemic ethanol when infused in the nucleus
accumbens (Hodge and Aiken, 1996; Hodge and Cox,
1998) or amygdala (Hodge and Cox, 1998). Together, this
evidence indicates that stimulation of GABAA receptors in
the nucleus accumbens by direct or allosteric modulation is
sufficient to produce discriminative stimulus effects that
correspond to those of systemic ethanol.
Substitution for ethanol by GABAA-positive modulators
varied as a function of brain region. When infused into the
nucleus accumbens, both 3-5-P and pentobarbital sub-
stituted fully for ethanol. However, when infused into the
hippocampus, both compounds produced only partial sub-
stitution. Because both brain regions have high levels of
GABAA receptors (Persohn et al., 1992; Pirker et al., 2000;
Rabow et al., 1995; Sperk et al., 1997; Wisden et al., 1992)
that are sensitive to the effects of ethanol (Crews et al.,
1996), this finding suggests that GABAA receptors in the
hippocampus may not be essential for discriminative
stimulus effects of ethanol. By contrast, infusions of the
noncompetitive NMDA antagonist MK-801 into the CA1
substitute fully for ethanol; this indicates that the actions
of ethanol at NMDA receptors in the region participate
in its discriminative stimulus effects (Hodge and Cox,
1998).
Differential brain region involvement in GABA-
mediated ethanol discrimination may reflect differential
expression and function of GABAA receptor subunits. The
GABAA receptor chloride ion channel complex is thought
to be a heteropentameric protein composed of subunits
that have been classified into five major families: 1 to 6,
1 to 3, 1 to 3, , and  (Luddens et al., 1995; Mac-
Donald and Olsen, 1994). Expression and assembly of
GABAA receptor subunit subtypes varies across brain re-
gions [see Rabow et al. (1995) and Sieghart (1995) for
reviews], and evidence suggests that neurosteroids and bar-
biturates may bind to separate modulatory sites on the
GABAA receptor (MacDonald and Olsen, 1994; Sieghart,
1992). In Xenopus oocytes expressing various combinations
of GABAA receptor subunits, the presence of the 2 sub-
unit decreased the efficacy of 3-5-P in receptors com-
posed of the 312 subunits (Shingai et al., 1991). Of
particular relevance to this study, 2 subunits of GABAA
receptors are considerably less abundant in the nucleus
accumbens as compared with the CA1 region of the hip-
pocampus (Rabow et al., 1995), and this could help clarify
why 3-5-P exhibited greater efficacy in the discriminative
stimulus effects of ethanol when infused in the nucleus
accumbens.
The two GABAA-positive modulators substituted for etha-
Fig. 4. Mean  SEM percentage of ethanol-appropriate responses (A) and
mean SEM total session response rate (B) plotted as a function of pentobarbital
dosage. Rats received pentobarbital injections in the nucleus accumbens (F, n 
9) or dorsal CA1 region of the hippocampus (, n  9). Data points to the left of
the x axis break represent control saline (S) or ethanol (E) ip performance com-
bined with sham microinjections. The horizontal dashed line (80%) represents
full substitution for the discriminative stimulus effects of ethanol (1.0 g/kg ip).
Drugs and doses were administered in a randomized order. *p  0.05 versus
saline.
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nol with differential potency when infused in the nucleus
accumbens. The ED50 for ethanol substitution by 3-5-P
(0.38  0.11 ng/l) was approximately 4000-fold lower than
the ED50 for substitution by pentobarbital (1.55 0.10g/l).
These results are consistent with previous studies that showed
that neurosteroids are extremely potent and positively modu-
late GABAA receptors at low nanomolar concentrations (Ma-
jewska et al., 1986; Morrow et al., 1987), whereas higher (i.e.,
micromolar) concentrations of pentobarbital are needed to
positively modulate GABAA receptor function (Akaike et al.,
1985; MacDonald et al., 1989).
In conclusion, results from this study indicate that nu-
cleus accumbens infusions of the GABAA-receptor-positive
modulators pentobarbital or 3-5-P substitute fully for
the discriminative stimulus effects of ethanol. This suggests
that site-specific activation of GABAA receptors in the
nucleus accumbens may be an important determinant of
the discriminative stimulus effects of systemically adminis-
tered ethanol. Moreover, activation of GABAA receptors
in the hippocampus (CA1) may not be critical for the
stimulus effects of ethanol.
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